fbpx
van icon

Receive $100 in free transportation to your medical appointments if you qualify. Check Eligibility

 
Back to Top

Amyloidosis

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Open - We are accepting applications for new and renewal patients. If your application for assistance is approved you can begin receiving funding immediately.

 

 

Assistance Amount

$7,800 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for amyloidosis.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level. 
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Actemra (tocilizumab)
  • Actemra Actpen (tocilizumab)
  • Active Injection Kit D (dexamethasone sodium phosphate/pf)
  • Alferon N (interferon alfa-n3)
  • Alkeran (melphalan)
  • Alkeran (melphalan hcl)
  • Astagraf Xl (tacrolimus)
  • Bortezomib (bortezomib)
  • Colchicine (colchicine)
  • Colcrys (colchicine)
  • Cyclophosphamide (cyclophosphamide)
  • Decadron (dexamethasone)
  • Dexamethasone Acetate La (dexamethasone acetate in sodium chloride, iso-osmotic)
  • Dexamethasone Acetate-sod Phos (dexamethasone acetate and sodium phosphate in sterile water)
  • Dexamethasone Intensol (dexamethasone)
  • Dexamethasone Sodium Phosphate (dexamethasone sodium phosphate)
  • Dexamethasone-0.9% Nacl (dexamethasone sodium phosphate in 0.9 % sodium chloride)
  • Dexpak (dexamethasone)
  • Dmt Suik (dexamethasone/pf/norflurane/pentafluoropropane (hfc 245fa))
  • Doubledex (dexamethasone sodium phosphate/pf)
  • Enbrel (etanercept)
  • Enbrel Mini (etanercept)
  • Enbrel Sureclick (etanercept)
  • Envarsus Xr (tacrolimus)
  • Evomela (melphalan hcl/betadex sulfobutyl ether sodium)
  • Humira Pen Psor-uveits-adol Hs (adalimumab)
  • Humira(cf) (adalimumab)
  • Humira(cf) Pediatric Crohn's (adalimumab)
  • Humira(cf) Pen Crohn's-uc-hs (adalimumab)
  • Ilaris (canakinumab/pf)
  • Inflectra (infliximab-dyyb)
  • Intron A (interferon alfa-2b,recomb.)
  • Kineret (anakinra)
  • Lidocidex-i (dexamethasone sodium phosphate/lidocaine hcl)
  • Locort (dexamethasone)
  • Mas Care-pak (dexamethasone sodium phosphate/pf)
  • Mitigare (colchicine)
  • Onpattro (patisiran sodium, lipid complex)
  • Pomalyst (pomalidomide)
  • Prograf (tacrolimus)
  • Protopic (tacrolimus)
  • Readysharp Dexamethasone (dexamethasone sodium phosphate)
  • Remicade (infliximab)
  • Renflexis (infliximab-abda)
  • Revlimid (lenalidomide)
  • Tacrolimus (tacrolimus)
  • Taperdex (dexamethasone)
  • Tegsedi (inotersen sodium)
  • Thalomid (thalidomide)
  • Velcade (bortezomib)
  • Vyndaqel (tafamidis meglumine)
  • Zodex (dexamethasone)
  • Zonacort (dexamethasone)

Diagnosis Codes:

ICD-10: E85.0, E85.1, E85.2, E85.3 , E85.4, E85.81, E85.82,E85.89, E85.9

 

About the Disease:

Amyloidosis is characterized by a build-up in amyloid protein in specific organs or throughout the body. It is a rare disease that affects multiple systems. Subtypes include amyloid A (AA) amyloidosis, immunoglobin light change amyloidosis (AL amyloidosis) and hereditary amyloidosis.

 

Source: National Institutes of Health